Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003212
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Both male and female, 18 years old <= aged <= 75 years old;
(2) The territory is limited to wuhan, hubei province;
(3) Voluntarily participate in the study and sign the informed consent.
(1) People with severe primary diseases such as heart, brain, liver, kidney and hematopoietic system;
(2) People with pulmonary malignancy;
(3) Combined with mental, intellectual or language disorders;
(4) Pregnant women, lactating women and those who have pregnancy requirement in the last 6 months;
(5) People who cannot skillfully use mobile phones or computers to fill in the questionnaire;
(6) People who are not willing to accept Chinese herbal tea, or those who have a history of allergy to Chinese herbal medicine;
(7) People who are using other Chinese herbal tea;
(8) People who had been diagnosed with covid-19 and recovered.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the rate of 2019-nCoV RNA positive;
- Secondary Outcome Measures
Name Time Method symptom;body temperature;